New SCITECH Tenant Could Put Columbus at Center of Emerging New Field in Medical Technology

Technique may revolutionize drug delivery systems for diabetes, cancer drugs

COLUMBUS - A new tenant of the Science and Technology Campus Corporation (SCITECH) promises to advance Central Ohio and The Ohio State University to the cutting edge of research in the newly emerging field of medical nanotechnology. The same techniques that create computer microchips can produce tiny medical devices which may revolutionize the world's medical drug delivery systems. The start-up company, which is relocating to Columbus from California's Silicon Valley, will explore products that may replace diabetics' frequent insulin injections with a one-time implantation of tiny silicon capsules beneath the skin. The same technology may give rise to cancer treatments that deliver drugs directly to a tumor, without subjecting patients to the often-debilitating effects of chemotherapy.